A novel preclinical strategy for identifying cardiotoxic kinase inhibitors and mechanisms of cardiotoxicity.


Abstract

Zebrafish may be a valuable preclinical tool to predict cardiotoxicity.

The α-adrenergic signaling pathway is an important modulator of sorafenib cardiotoxicity in vitro and in vivo and appears to act through a here-to-fore unrecognized signaling pathway downstream of α-adrenergic activation that bypasses Raf to activate ERKs.


Full Text


Subjects


Similar articles

Español | English

© Galenicom 1999-2013